Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Fixed Capital/Sales

    Back to All Ratios
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.370.350.370.310.25

What is the latest Fixed Capital/Sales ratio of WINDLAS BIOTECH ?

The latest Fixed Capital/Sales ratio of WINDLAS BIOTECH is 0.37 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.37
Mar20230.35
Mar20220.37
Mar20210.31
Mar20200.25

How is Fixed Capital/Sales of WINDLAS BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.37
5.71
Mar2023 0.35
-5.41
Mar2022 0.37
19.35
Mar2021 0.31
24.00
Mar2020 0.25 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Fixed Capital/Sales ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹2,057.1 Cr -0.9% -5.9% 76.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,314.0 Cr -0.4% 5.7% 20.2% Stock Analytics
DIVIS LABORATORIES ₹162,809.0 Cr 1.7% 6.2% 52.9% Stock Analytics
CIPLA ₹124,627.0 Cr -0.7% 7% 8.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,127.0 Cr -1.6% 1.5% 21.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,839.9 Cr -2.3% 2.5% -6% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-0.9%

-5.9%

76.5%

SENSEX

2%

4.1%

9.6%


You may also like the below Video Courses